- Provide a review of new information on the basic pathophysiology of ventricular arrhythmias
- Provide an in-depth understanding of current management strategies used for the care of ventricular arrhythmias in various disease states, including non-pharmacological therapies such as implantable device and catheter ablation techniques.
Upon completion of this activity, participants should be able to:
- Describe the science critical to the understanding and treatment of ventricular arrhythmias including:
- The role of the autonomic nervous system in ventricular arrhythmogenesis.
- Biophysics of ablation
- Anatomic substrate for ventricular tachycardia (VT)
- Review the current status and future role for implantable cardioverter-defibrillators (ICD) in the management of sudden cardiac death.
- Describe the role of remote monitoring and genetic testing in the management/evaluation of patients with structural heart disease and VT
- Discuss the role of new techniques for VT substrate assessment including body surface mapping (ECGI), MRI, voltage guided biopsy and high density mapping
- Describe risk stratification and treatment including VT ablation and myomectomy in hypertrophic cardiomyopathy
- Discuss strategies to improve treatment outcome in patients with ventricular arrhythmias and structural heart disease including “bail out” strategies after failed catheter ablation
- Explain the current use/role of antiarrhythmic drug therapy for ventricular arrhythmias
- Identify techniques to improve ablation success for idiopathic arrhythmias including use of advanced imaging
- Describe the status of ongoing multicenter VT related trials and discuss which questions need to be answered by trials in the future.